Embracing model-based designs for dose-finding trials by Love, SB, Brown, S, Weir, CJ, Harbron, C, Yap, C, Gaschler-Markefski, B, Matcham, J

Home monitoring of breathing rate in people with chronic obstructive pulmonary disease: observational study of feasibility, acceptability, and change after exacerbation by Rubio N, Parker RA, Drost EM, Pinnock H, Weir CJ, Hanley J, Mantoani LC, McKinstry B, Rabinovich RA

Get full text

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE by Manyara, AM, Davies, P, Stewart, D, Weir, CJ, Young, A, Butcher, NJ, Bujkiewicz, S, Chan, A-W, Collins, GS, Dawoud, D, Offringa, M, Ouwens, M, Ross, JS, Taylor, RS, Ciani, O

Adaptive designs in clinical trials: why use them, and how to run and report them by Pallmann, P, Bedding, AW, Choodari-Oskooei, B, Dimairo, M, Flight, L, Hampson, LV, Holmes, J, Mander, AP, Odondi, L, Sydes, MR, Villar, SS, Wason, JMS, Weir, CJ, Wheeler, GM, Yap, C, Jaki, T

Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review by Manyara, AM, Davies, P, Stewart, D, Weir, CJ, Young, AE, Wells, V, Blazeby, J, Butcher, NJ, Bujkiewicz, S, Chan, A-W, Collins, GS, Dawoud, D, Offringa, M, Ouwens, M, Ross, JS, Taylor, RS, Ciani, O

Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design by Dimairo, M, Coates, E, Pallmann, P, Todd, S, Julious, SA, Jaki, T, Wason, J, Mander, AP, Weir, CJ, Koenig, F, Walton, MK, Biggs, K, Nicholl, J, Hamasaki, T, Proschan, MA, Scott, JA, Ando, Y, Hind, D, Altman, DG

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study by Solovyeva, O, Dimairo, M, Weir, CJ, Hee, SW, Espinasse, A, Ursino, M, Patel, D, Kightley, A, Hughes, S, Jaki, T, Mander, A, Evans, TRJ, Lee, S, Hopewell, S, Rantell, KR, Chan, A-W, Bedding, A, Stephens, R, Richards, D, Roberts, L, Kirkpatrick, J, de Bono, J, Yap, C

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials by Ciani, O, Manyara, AM, Davies, P, Stewart, D, Weir, CJ, Young, AE, Blazeby, J, Butcher, NJ, Bujkiewicz, S, Chan, A-W, Dawoud, D, Offringa, M, Ouwens, M, Hróbjartssson, A, Amstutz, A, Bertolaccini, L, Bruno, VD, Devane, D, Faria, CDCM, Gilbert, PB, Harris, R, Lassere, M, Marinelli, L, Markham, S, Powers, JH, Rezaei, Y, Richert, L, Schwendicke, F, Tereshchenko, LG, Thoma, A, Turan, A, Worrall, A, Christensen, R, Collins, GS, Ross, JS, Taylor, RS